Present and future roles of FDG-PET/CT imaging in the management of lung cancer |
| |
| Authors: | Kazuhiro Kitajima Hiroshi Doi Tomonori Kanda Tomohiko Yamane Tetsuya Tsujikawa Hayato Kaida Yukihisa Tamaki Kozo Kuribayashi |
| |
| Institution: | 1.Division of Nuclear Medicine and PET Center, Department of Radiology,Hyogo College of Medicine,Nishinomiya,Japan;2.Department of Radiology,Hyogo College of Medicine,Nishinomiya,Japan;3.Department of Radiology,Teikyo University School of Medicine,Tokyo,Japan;4.Department of Nuclear Medicine, Saitama International Medical Center,Saitama Medical University,Hidaka,Japan;5.Department of Biomedical Imaging Research Center,Fukui University,Eiheiji-cho,Japan;6.Department of Radiology,Kinki University Faculty of Medicine,Osakasayama,Japan;7.Department of Radiation Oncology,Shimane University School of Medicine,Izumo,Japan;8.Division of Respiratory Medicine, Department of Internal Medicine,Hyogo College of Medicine,Nishinomiya,Japan |
| |
| Abstract: | Integrated positron emission tomography/computed tomography (PET/CT) using 2-18F]fluoro-2-deoxy-d-glucose (18F-FDG) has emerged as a powerful tool for combined metabolic and anatomic evaluation in clinical oncologic imaging. This review discusses the utility of 18F-FDG PET/CT as a tool for managing patients with lung cancer. We discuss different patient management stages, including diagnosis, initial staging, therapy planning, early treatment response assessment, re-staging, and prognosis. |
| |
| Keywords: | |
| 本文献已被 SpringerLink 等数据库收录！ |
|
